DexCom Inc
DXCM: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| j#< | LOCK|%yjyX | LOCK|B<dl^z?P |
DexCom Earnings: Another Solid Quarter Highlights Operational Improvements in 2026
DexCom's second-quarter results included solid 11% year-over-year growth in US revenue, while international sales rose more strongly at 16% in constant currency.
